G. Gebrael

发表

Enhancing Triage Efficiency and Accuracy in Emergency Rooms for Patients with Metastatic Prostate Cancer: A Retrospective Analysis of Artificial Intelligence-Assisted Triage Using ChatGPT 4.0

N. Agarwal, U. Swami, B. Maughan, 2023, Cancers.

Treatment Patterns and Attrition With Lines of Therapy for Advanced Urothelial Carcinoma in the US

N. Tripathi, V. Mathew Thomas, Y. Jo, 2024, JAMA network open.

Differential Tumor Gene Expression Profiling of Patients With Prostate Adenocarcinoma on the Basis of BMI.

Kamalakanta Sahu, N. Tripathi, V. Mathew Thomas, 2024, JCO precision oncology.

Treatment Patterns and Outcomes by Age in Metastatic Urinary Tract Cancer: A Retrospective Tertiary Cancer Center Analysis

Kamalakanta Sahu, N. Tripathi, V. Mathew Thomas, 2024, Cancers.

Advances in the treatment of metastatic prostate cancer.

N. Agarwal, U. Swami, G. G. Fortuna, 2023, Trends in cancer.

Predictors of response to neoadjuvant therapy in urothelial cancer.

V. Thomas, N. Tripathi, G. G. Fortuna, 2023, Critical reviews in oncology/hematology.

Natural course of metastatic castration‐resistant prostate cancer in the era of intensified androgen deprivation therapy in the hormone‐sensitive setting

N. Tripathi, V. Mathew Thomas, Y. Jo, 2024, The Prostate.

Impact of Initial Timing of Metastatic Disease on Survival in Patients With Newly Diagnosed Metastatic Castration-Resistant Prostate Cancer Treated With Androgen Receptor Pathway Inhibitors

N. Agarwal, B. Maughan, A. Chehrazi-Raffle, 2023, Urology practice.

Impact of androgen receptor alterations on cell‐free DNA genomic profiling on survival outcomes in metastatic castration‐resistant prostate cancer

N. Agarwal, U. Swami, B. Maughan, 2023, The Prostate.

Survival outcomes of real world patients with metastatic hormone-sensitive prostate cancer who do not achieve optimal PSA response with intensified androgen deprivation therapy with docetaxel or androgen receptor pathway inhibitors

N. Agarwal, B. Maughan, V. Thomas, 2023, Prostate cancer and prostatic diseases.

Differences in Tumor Gene Expression Profiles Between De Novo Metastatic Castration-sensitive Prostate Cancer and Metastatic Relapse After Prior Localized Therapy.

B. Maughan, Haoran Li, Kamalakanta Sahu, 2024, European urology oncology.

Outcomes of patients with brain metastases from renal cell carcinoma treated with first-line therapies: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).

T. Choueiri, I. Davis, A. Kapoor, 2023, Journal of Clinical Oncology.